Researchers speculate that Menin may be the key protein connecting the genetic, inflammatory and metabolic factors of aging.
Bacteriophages deploy a sneaky tactic when targeting their hosts: they use a standard genetic code when invading bacteria, then switch to an alternate code at later stages of infection.
The study found 42 areas across the genome that harbour variants that increase the risk of endometriosis.
Through whole-genome sequencing, researchers uncovered important information about Beethoven's health and posed new questions about his ancestry and cause of death.
The same genetics that helped some of our ancestors fight the plague are still likely to be at work in our bodies today.
The concept of using peptides to block the effects of the damaging repeat expanded RNA and toxic repeat proteins could transform how some neurodegenerative conditions are treated.
The gene ALPK3, which controls the heart's capacity to beat normally, has been shown to increase cardiomyopathy risk when mutated.
Researchers have improved the efficiency of molecular genetic methods such as CRISPR/Cas9 and related systems, while broadening their areas of application.
Several genes that cause a rare childhood cancer have been identified in the first comprehensive genetic map of sarcomas.
Researchers say they have presented the first evidence of 12-hour cycles of gene activity in the human brain, and that some of those 12-hour rhythms are missing or altered in patients with schizophrenia.
An anti-aging gene discovered in a population of centenarians has been shown to rewind the heart's biological age by 10 years.
Researchers at Nagoya University have identified a novel genetic variant found in some patients with amyotrophic lateral sclerosis (ALS).
Researchers have found a mutation in the thrombospondin-1 (THBS1) gene in three ethnically and geographically diverse families with childhood glaucoma histories.
Scientists have revealed new insights into intrinsically disordered proteins and protein regions and how they behave under various physiological processes.
Unlike any other previously known nuclease of the CRISPR-Cas immune system, the newly dubbed 'Cas12a2' destroys DNA to shut down an infected cell.